The Immune System – News and Features

Akorn receives exclusive marketing and distribution rights to North, Central, and South America.

With the collaboration agreement in place with IZSLER, GeneThera can now advance previous research work.

The Centers bring together basic and clinical research in a way that helps translate basic discoveries into new drugs, treatments and diagnostics.

The findings suggest that it could be possible to develop embryonic stem cell vaccines that prevent cancers in humans at high risk of developing cancer.

Tulane University researchers have said that adult stem cells increase insulin production in mice with type 2 diabetes.

Dicer-substrate RNAi technology could offer increased potency for drug development as compared to conventional RNAi technology.

Scientists demonstrate inhibition of acute lung injury and cell death in animals with administration of small interfering RNAs.

The RITT Industrial BioDevelopment Laboratory has been equipped with over $1,000,000 (Canadian) of Thermo laboratory equipment.

Discovery could accelerate stem cell research, development of new disease treatments.

These patents cover the company’s ssDNA expression system covered by a US patent and by several patent applications in major world markets.